Topamax Promotions Draw FDA Warning Letter For Omitted Safety Information
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency cites J&J website and sales aid for making tolerability claims without including sufficient risk information.
You may also be interested in...
Topamax Launch For Migraine Prevention Includes Unbranded DTC Ad
Rollout of Ortho-McNeil's disease awareness ad coincides with sales force launch meeting for the new indication. The ad directs patients to a toll-free phone number and a website.
Topamax Launch For Migraine Prevention Includes Unbranded DTC Ad
Rollout of Ortho-McNeil's disease awareness ad coincides with sales force launch meeting for the new indication. The ad directs patients to a toll-free phone number and a website.
J&J Viadur Promotional Aid Omits Risk Information, FDA Warning Letter Says
A patient disc puzzle includes no risk information, FDA said. The promotion's references to Viadur's website and toll-free number do not satisfy risk disclosure requirements.